|
|
|
|
|
|
by avani
2509 days ago
|
|
|
It's not quite _discovering_ a target from NGS, but lots of existing cancer drugs are targeted based on genotyping tumours. Breast cancer is the classic one, where, say, if you can quickly determine if your sample is Her2+ your treatment plan drastically changes. Now, getting enough cancer cells in your tumour sample to reliably genotype at that stage is a separate hard problem. |
|
|